Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Asayuki Iwai"'
Autor:
Hidehiro Takahashi, Yusuke Okuno, Shouichi Ohga, Takako Aoki, Seishi Ogawa, Hiromi Ogura, Satoru Miyano, Seiji Kojima, Hitoshi Kanno, Kenichi Yoshida, Taiju Utsugisawa, Asayuki Iwai, Toshiyuki Yamamoto, Keiko Yamamoto-Shimojima, Kenichiro Watanabe
Publikováno v:
Human Genome Variation
Genetic causes of undiagnosed hemolytic anemia in nineteen patients were analyzed by whole-exome sequencing, and novel COL4A1 variants were identified in four patients (21%). All patients were complicated with congenital malformations of the brain, s
Autor:
Kimiko Ubukata, Naoko Nishikawa-Nakamura, Satoshi Iwata, Keiko Nishimura, Takafumi Okada, Asayuki Iwai, Tsuyako Iwai
Publikováno v:
Journal of Infection and Chemotherapy. 23:785-787
Streptococcus pneumoniae is a main causative agent of serious invasive bacterial infections. However, concurrent infection with invasive pneumococcal disease (IPD) and viral infectious mononucleosis (IM) is rare. We report an infant with serotype 6C
Autor:
Fakrudeen Shafi, Akari Suyama, Tomohide Sato, Tomohiro Oishi, Naohisa Kawamura, Haruo Kuroki, Asayuki Iwai, Javier Ruiz-Guiñazú, Satoshi Iwata, Mitsunobu Miyazu, Nancy François, Yasunobu Tokoeda, Dorota Borys
Publikováno v:
Human Vaccines & Immunotherapeutics
This phase III, randomized, open-label, multicenter study (NCT01027845) conducted in Japan assessed the immunogenicity, safety, and reactogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV, give
Autor:
Nobuyuki Hyakuna, Urara Kohdera, Miharu Yabe, Tetsunori Funabiki, Satoshi Kataoka, Hisaya Nakadate, Yasunori Toyoda, Masahiro Sako, Kazuhiro Muramatsu, Takashi Fukushima, Asayuki Iwai, Shinsaku Imashuku, Koichiro Ikuta, Eiichi Ishii, Katsuhiko Kitazawa
Publikováno v:
Cancer. 94:3023-3031
BACKGROUND Familial hemophagocytic lymphohistiocytosis HLH (FHL) is fatal, unless patients are rescued with hematopoietic stem cell transplantation (SCT). Although the molecular identification of FHL now is possible at least in part from perforin gen
Autor:
Haruhiko Eguchi, Masue Imaizumi, Yasuo Horikoshi, Kenichi Koike, Tsutomu Watanabe, Atsushi Kikuta, Yoichi Takaue, Asayuki Iwai, Yoshifumi Kawano, Arata Watanabe, Atsushi Makimoto, Yasuhiro Kuroda, Shigeru Ohta
Publikováno v:
Biology of Blood and Marrow Transplantation. 8:26-31
Allogeneic peripheral blood stem cell transplantation (PBSCT) was performed in children and adolescents for the treatment of malignant (n = 49) and nonmalignant hematological disease (n = 8). Granulocyte colony-stimulating factor (G-CSF)-mobilized PB
Autor:
Tsuyako Iwai, Asayuki Iwai, Naoko Nakano, Kozo Nagai, Eiichi Ishii, Kouichi Ohshima, Hisamichi Tauchi
Publikováno v:
Pediatric hematology and oncology. 31(6)
Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is a rare type of skin lymphoma. Histopathology mimicking a lobular panniculitis makes it difficult to distinguish SPTL from benign autoimmune disease. We present cases of a 10-year-old female and
Autor:
Takashi Taga, Norio Onodera, Masahito Tsurusawa, Tsutomu Watanabe, Nobuyuki Hyakuna, Tetsuo Kawakami, Kazuo Gushi, Takeo Fujimoto, Munenori Miyake, Akiko Kato, Arata Watanabe, Hirokazu Kanegane, Atsushi Kikuta, Asayuki Iwai, Junichi Mimaya, Tanaka Atsushi, Takeji Matsushita, Isao Sekine, Osamu Izichi, Yoshio Hatae, Keiko Asami, Ari Nakamura
Publikováno v:
Leukemia & Lymphoma. 42:393-398
To evaluate the clinical implications of CD45 expression in acute childhood lymphoblastic leukemia (ALL), we measured the CD45 expression of blast cells from 133 untreated patients with childhood B-precursor ALL (n = 118) or T-ALL (n = 15). CD45 expr
Autor:
Hideo Mugishima, T Hirota, Takeo Takeda, Kenichi Anami, Asayuki Iwai, Osamu Ijichi, Kenichi Nishikawa, Masahito Tsurusawa, Yosirou Hatae, Shigeru Ota, Keiko Asami, Toshiki Gushiken, Teruhisa Furuyama, Takeo Fujimoto, Naoyuki Katano, Atsushi Kikuta, Munenori Miyake, Syoichi Koizumi, Arata Watanabe, Kunihiro Nishi, Michio Yatabe, Yoshifumi Kawano, Isao Sekine, Yamamoto Y, Junichi Mimaya, Hirokazu Kanegane
Publikováno v:
Medical and Pediatric Oncology. 32:259-266
Background Prevention of central nervous system (CNS) leukemia by early introduction of therapy to this sanctuary site is an essential component of modern treatment strategy for acute lymphoblastic leukemia (ALL). However, the optimal form of prevent
Autor:
Shoichi Koizumi, K Nishikawa, Tsuneo Ninomiya, Toshiki Gushiken, Isao Sekine, Yasushi Ishida, Takeo Fujimoto, Y Takaue, Atsushi Kikuta, Keiko Asami, Yasukazu Yamamura, Kiyoshi Kawakami, Takuya Yanase, Teruhisa Furuyama, Asayuki Iwai, Takayoshi Tsuchiya, Shinn Watanabe, Ken Kimura, Junichi Mimaya, Munenori Miyake, Nobuaki Ariyoshi, Tatsuo Shimokawa, Oka T, Shigeru Ohta, Takeji Matsushita
Publikováno v:
Pediatric Hematology and Oncology. 14:17-28
Since 1981, the Children's Cancer and Leukemia Study Group (CCLSG) has developed a series of protocols for treatment of acute lymphoblastic leukemia (ALL) in childhood. In the first randomized controlled study of the 811 protocol (1981-1983) a compar
Autor:
Takashi Taga, Masahito Tsurusawa, Yutaka Saikawa, Atsushi Kikuta, Asayuki Iwai, Hiroyuki Shichino, Akiko Inoue, Yasuo Horikoshi, Toshinori Hori, Arata Watanabe, Junichi Ueyama, Keiko Nomura, Yasuto Shimomura, Michihiro Yano, Shouhei Yokota, Masahiko Okada, Motoaki Chin, Atsushi Ogawa, Yasuhiro Okamoto, Chihaya Imai
Publikováno v:
Blood. 126:3724-3724
BACKGROUND: Minimal residual disease (MRD) level after induction (Time Point1:TP1) and before consolidation therapy (Time Point2:TP2) has a strong impact in prediction of outcome for childhood acute lymphoblastic leukemia and it has clinical utility